United Res Labs Company Profile
✉ Email this page to a colleague
What is the competitive landscape for UNITED RES LABS, and what generic and branded alternatives to UNITED RES LABS drugs are available?
UNITED RES LABS has three approved drugs.
Drugs and US Patents for United Res Labs
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
United Res Labs | OXAZEPAM | oxazepam | CAPSULE;ORAL | 071026-003 | Aug 10, 1987 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
United Res Labs | COLESEVELAM HYDROCHLORIDE | colesevelam hydrochloride | TABLET;ORAL | 213456-001 | Jan 21, 2022 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
United Res Labs | OXAZEPAM | oxazepam | CAPSULE;ORAL | 071026-001 | Aug 10, 1987 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.